Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
1:19-cv-02216
Overview
Parties
Intervenor
Par Pharmaceutical Inc. Operating Company
Represented By
1 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Counter Claimant
Mylan Pharmaceuticals Inc. Operating Company
Represented By
8 Attorneys ListedMorris James LLP
3205 Avenue North Boulevard, Suite 100
Morris James LLP
3205 Avenue North Boulevard, Suite 100
Counter Defendant
Takeda Pharmaceuticals U.S.A., Inc. Operating Company
Represented By
8 Attorneys ListedConnolly Gallagher LLP
1201 N. Market St., 20th Floor
Faegre Drinker Biddle & Reath LLP
222 Delaware Avenue, Suite 1410
Faegre Drinker Biddle & Reath LLP
222 Delaware Avenue, Suite 1410
Third Party Defendant
Hikma Pharmaceuticals International Limited NPE (University / Research)
Represented By
1 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
222 Delaware Avenue, Suite 900
Hikma Pharmaceuticals USA Inc. Operating Company
Represented By
1 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
222 Delaware Avenue, Suite 900
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Takeda Pharmaceuticals U.S.A., Inc. v. Scilex Pharmaceuticals Inc.
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc.
Takeda Pharmaceuticals USA Inc. v. Par Pharmaceutical Companies Inc.
Takeda Pharmaceuticals U.S.A. Inc. v. Par Pharmaceutical Inc.
Patents Involved
There are 17 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7906519
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2010-08-18
Issued: 2011-03-15
|
Active (3.7 yrs remaining)
Expires: 2030-08-18
|
|
|
US7935731
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2010-05-25
Issued: 2011-05-03
|
Active (3.5 yrs remaining)
Expires: 2030-05-25
|
|
|
US8093298
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2011-05-18
Issued: 2012-01-10
|
Active (4.5 yrs remaining)
Expires: 2031-05-18
|
|
|
US7964648
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2010-01-15
Issued: 2011-06-21
|
Active (3.2 yrs remaining)
Expires: 2030-01-15
|
|
|
US8093297
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2011-04-22
Issued: 2012-01-10
|
Active (4.4 yrs remaining)
Expires: 2031-04-22
|
|
|
US7619004
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2008-12-03
Issued: 2009-11-17
|
Active (2.0 yrs remaining)
Expires: 2028-12-03
|
|
|
US7601758
Methods for concomitant administration of colchicine and macrolide antibiotics in the treatment of gout flares
|
Filed: 2009-02-10
Issued: 2009-10-13
|
Active (2.2 yrs remaining)
Expires: 2029-02-10
|
|
|
US7820681
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2009-02-17
Issued: 2010-10-26
|
Active (2.2 yrs remaining)
Expires: 2029-02-17
|
|
|
US7915269
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2010-08-18
Issued: 2011-03-29
|
Active (3.7 yrs remaining)
Expires: 2030-08-18
|
|
|
US7964647
Colchicine compositions and methods
|
Filed: 2009-03-20
Issued: 2011-06-21
|
Active (2.3 yrs remaining)
Expires: 2029-03-20
|
|
|
US7981938
Colchicine compositions and methods
|
Filed: 2010-01-14
Issued: 2011-07-19
|
Active (3.1 yrs remaining)
Expires: 2030-01-14
|
|
|
US8093296
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2011-04-20
Issued: 2012-01-10
|
Active (4.4 yrs remaining)
Expires: 2031-04-20
|
|
|
US8097655
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2011-05-17
Issued: 2012-01-17
|
Active (4.5 yrs remaining)
Expires: 2031-05-17
|
|
|
US8415395
Colchicine compositions and methods
|
Filed: 2012-04-19
Issued: 2013-04-09
|
Active (5.4 yrs remaining)
Expires: 2032-04-19
|
|
|
US8415396
Colchine compositions and methods
|
Filed: 2012-04-20
Issued: 2013-04-09
|
Active (5.4 yrs remaining)
Expires: 2032-04-20
|
|
|
US8440721
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2011-07-18
Issued: 2013-05-14
|
Active (4.7 yrs remaining)
Expires: 2031-07-18
|
|
|
US8440722
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2012-04-24
Issued: 2013-05-14
|
Active (5.4 yrs remaining)
Expires: 2032-04-24
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
115
Dispositive
92
Granted
10
Denied
2
Pending / Review
77
Motions by Category
Key Dispositive Motions & Rulings